Medvantx Acquires RxS to Broaden Integrated Access & Engagement Solutions for Life Science
Combined company will leverage services and technology platforms to offer a broad portfolio of integrated solutions to pharmaceutical and device...
Pharmaceutical
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress
MIAMI and JERUSALEM, July 08, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (“OPKO”) and Entera Bio Ltd. (NASDAQ:...
Nuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting NXP900’s Potential as a Combination Partner with Leading Therapies
Drug-drug interaction (“DDI”) clinical studies help identify the potential for side effects, or in some cases, reduced therapeutic efficacy, that...
ZyVersa Therapeutics Supports FDA-Authorized Emergency Compassionate Use of Cholesterol Efflux Mediator™ VAR 200 in a Patient with ApoCII Amyloidosis
ApoCII amyloidosis, resulting from abnormal organ deposition of toxic fibrillar amyloid proteins, is an ultra-rare condition that mostly affects the...
Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
Substantial clinical need expected to facilitate rapid overall trial enrollmentHOUSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq:...
Eupraxia Doses First Patient in Phase 2b Placebo-Controlled Portion of EP-104GI RESOLVE Trial in Eosinophilic Esophagitis
Dosing of the first patient in Phase 2b marks an important transition of the RESOLVE trial from a Phase 2a...
Diagonal Therapeutics Appoints John Lee, M.D., Ph.D., as Chief Medical Officer
Biotech veteran will lead clinical development of Diagonal’s clustering antibody pipeline, including DIAG723 for hereditary hemorrhagic telangiectasia (HHT) and pulmonary...
Agios Appoints Dr. Jay Backstrom to Board of Directors
CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate...
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
- NDA assigned a Target Action Date of February 25, 2026 -- Product has patent protection through 2044 - DEER...
AB Science announces the successful completion of a EUR 1.925 million private placement
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 1.925 MILLION PRIVATE PLACEMENT Paris, July 8, 2025, 8am...
Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a...
Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance
ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage...
Boehringer Ingelheim Harnesses GenAI to Transform Case Intake with LifeSphere® NavaX™
Global Biopharma Leader Streamlines Pharmacovigilance with 90% Data Accuracy and Enhanced Efficiency BOSTON, July 8, 2025 /PRNewswire/ -- ArisGlobal, an AI-first...
Veeda Lifesciences announces partnership with Mango Sciences to bring AI innovation in clinical trials services
AHMEDABAD, India, July 8, 2025 /PRNewswire/ -- Veeda Lifesciences, a global contract research organization (CRO), has announced an investment in...
KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on...
Sitero Signs Agreement to Acquire Axiom Real-Time Metrics, Expanding Global Footprint and Strengthening Technology-Enabled Clinical Services
MIAMI, Fla., July 7, 2025 /PRNewswire/ -- Sitero, a leading provider of clinical and regulatory services, today announced that it...
GE HealthCare to announce second quarter 2025 results on July 30, 2025
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its second quarter 2025 financial results before the market opens on Wednesday, July...
Health Union Unveils Innovative 2026 DTC Product Suite, Revolutionizing Patient Engagement with AI and Dynamic Experiences
PHILADELPHIA, July 7, 2025 /PRNewswire/ -- Health Union, the leading digital health company for online community-based activation and data, is...
Doctors Are Being Outpaced by AI-Powered Algorithms — Here’s What It Means for Investors
USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 7, 2025 /PRNewswire/ -- USA News...
VIOME COLLABORATES WITH MICROSOFT TO DELIVER PREVENTIVE HEALTHCARE WITH ONE OF WORLD’S LARGEST RNA DATASETS
Viome's AI-Powered Platform Delivers Personalized Health Insights and Redefines Wellness Worldwide, Integrating Microsoft Azure BELLEVUE, Wash., July 7, 2025 /PRNewswire/...